Anika Therapeutics (ANIK) Other Non-Current Assets: 2010-2025
Historic Other Non-Current Assets for Anika Therapeutics (ANIK) over the last 15 years, with Sep 2025 value amounting to $5.5 million.
- Anika Therapeutics' Other Non-Current Assets fell 51.31% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 51.31%. This contributed to the annual value of $5.7 million for FY2024, which is 84.42% down from last year.
- According to the latest figures from Q3 2025, Anika Therapeutics' Other Non-Current Assets is $5.5 million, which was down 0.77% from $5.5 million recorded in Q2 2025.
- In the past 5 years, Anika Therapeutics' Other Non-Current Assets registered a high of $36.3 million during Q4 2023, and its lowest value of $5.5 million during Q3 2025.
- Over the past 3 years, Anika Therapeutics' median Other Non-Current Assets value was $17.6 million (recorded in 2024), while the average stood at $14.9 million.
- Per our database at Business Quant, Anika Therapeutics' Other Non-Current Assets soared by 110.84% in 2023 and then plummeted by 84.42% in 2024.
- Anika Therapeutics' Other Non-Current Assets (Quarterly) stood at $20.3 million in 2021, then decreased by 15.11% to $17.2 million in 2022, then spiked by 110.84% to $36.3 million in 2023, then tumbled by 84.42% to $5.7 million in 2024, then plummeted by 51.31% to $5.5 million in 2025.
- Its Other Non-Current Assets stands at $5.5 million for Q3 2025, versus $5.5 million for Q2 2025 and $5.7 million for Q1 2025.